Thank you for the articles, Chaplain. I wanted to pin your post because the information really pertains to much more than just Long Covid.
For instance, some of the information you provided notes that, "Long COVID Now Looks like a Neurological Disease, Helping Doctors to Focus Treatments
The causes of long COVID, which disables millions, may come together in the brain and nervous system"
This brain and neurological connection impacted my wife, and almost 2 years ago I wrote, "I think an important aspect of (a then-recent study) could evolve, centered on preventing and treating neurological indications such as encephalopathy or encephalitis. These brain disorders can impair patients' abilities to see, hear, talk, and exercise motor control. Patients are effectively locked-up inside of themselves, with no way to communicate."
Additional information you provided was in regards to reinfections, which is a key subject of interest to me, as I would really like to see some data on the reinfection rate in lenz patients. But I was unaware of the practically determinant role disease severity played in patients getting re-infected.
"Among those hospitalized with severe COVID the first time around, nearly half were hospitalized again when reinfected. Conversely, roughly 90 percent of people with mild initial infections avoided hospitalization when sickened again with COVID later."
In addition, one study found that, "...reinfected people are twice as likely to die and three times as likely to be hospitalized with COVID than those infected only once."
I think the information you provided is basically a primer on how covid manifests into an incredibly large array of subsequent indications, which sets the treating physicians off on treating all those indications. But I think effort should also be on restoring the immune response system in these reinfected patients with a history of previous serious covid infection. I really hope Humanigen could factor this into their cost/benefit analysis of the value of lenz.
